Introduction to the FDA Guidance Drug Interaction Information in Human Prescription Drug and Biological Product Labeling and Its Implications

doi:10.3969/j.issn.1673-5390.2026.07.010

XIAO Hui-lai

China Food Drug Administration ›› 2026, Vol. 0 ›› Issue (7) : 100-107.

PDF(1547 KB)

China Food Drug Administration ›› 2026, Vol. 0 ›› Issue (7) : 100-107. DOI: 10.3969/j.issn.1673-5390.2026.07.010

International Regulations

Introduction to the FDA Guidance Drug Interaction Information in Human Prescription Drug and Biological Product Labeling and Its Implications

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2026, 0(7): 100-107 https://doi.org/10.3969/j.issn.1673-5390.2026.07.010

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

Funding

RIGHTS & PERMISSIONS

PDF(1547 KB)

Accesses

Citation

Detail

Sections

Recommended

Please choose a citation manager

Content to export